Unconventional Health Solutions
Proprietary medical devices, developed in Italy for markets seeking clinical differentiation and supply continuity.
Alfakjn develops and manufactures medical devices for selected therapeutic areas, collaborating with local partners who want to introduce reliable, regulatory-sound solutions supported by technical materials into their portfolio.
Unconventional Health Solutions
Proprietary medical devices, developed in Italy for markets seeking clinical differentiation and supply continuity.
Alfakjn develops and manufactures medical devices for selected therapeutic areas, collaborating with local partners who want to introduce reliable, regulatory-sound solutions supported by technical materials into their portfolio.
An Italian medical device company, oriented towards international markets
Founded in 2012, Alfakjn combines proprietary development, Italian manufacturing and collaboration with local distribution partners. Our work stems from identifying as yet unmet clinical needs and translates into medical devices designed to generate value across the entire supply chain: for the distributor who introduces them to the market, for the healthcare professional who uses them, and for the patient who benefits from them.
We operate in therapeutic areas where innovation is not just a matter of formulation, but of positioning, manufacturing continuity, regulatory documentation and the ability to adapt the product narrative to different local contexts.
An Italian medical device company, oriented towards international markets
Founded in 2012, Alfakjn combines proprietary development, Italian manufacturing and collaboration with local distribution partners. Our work stems from identifying as yet unmet clinical needs and translates into medical devices designed to generate value across the entire supply chain: for the distributor who introduces them to the market, for the healthcare professional who uses them, and for the patient who benefits from them.
We operate in therapeutic areas where innovation is not just a matter of formulation, but of positioning, manufacturing continuity, regulatory documentation and the ability to adapt the product narrative to different local contexts.
One website, two paths for further study
For healthcare distributors and buyers
If you are evaluating new solutions to add to your portfolio, here you will find an initial overview of the Alfakjn value: covered areas, product differentiation, regulatory assets, support materials and collaboration model.
For healthcare professionals
If you are a doctor, a pharmacist or a healthcare professional, you can explore the therapeutic areas, the available product lines and the documentation intended for professional use.
Numbers that tell the story of a supply chain
+ k
+1
Six therapeutic areas, a common development rationale
Alfakjn focuses its portfolio on areas where clinical need is real and the market still leaves room for differentiating solutions. Each area is designed to offer the distributor a clear, sustainable proposition supported by technical materials, without losing the rigor required by the healthcare professional.
Injuries and radiodermatitis
Solutions for wound care, burns and skin support in specialist settings, including radiodermatitis. The Corakjn line — available in Corakjn cream, Corakjn C gel, Corakjn C spray, Corakjn gauze and Corakjn Ag versions — makes it possible to address various needs with formats and materials suited to the clinical and commercial presentation.
Consumer Health
Accessible solutions to broaden portfolio coverage even beyond the specialist channel, while maintaining a professional approach consistent with Alfakjn's medical identity. The area includes Lice Out Preventivo, a preventive spray for protection against head lice; Medusil, a spray to reduce pain and stinging irritation from jellyfish contact; and LiHanna Spray, a topical solution for the relief of hyperhidrosis and menopausal hot flushes.
Why evaluate Alfakjn as a distribution partner
For a distributor, introducing a new brand does not just mean adding product lines. It means understanding whether that brand can strengthen the portfolio, protect commercial positioning and generate long-term continuity. Alfakjn works across four dimensions of value.
Product differentiation
Proprietary formulations, active patents and ranges designed for selected clinical areas enable the distributor to offer solutions that do not overlap with commodities already on the market.
2. Operational reliability
Development and production in Italy, combined with regulatory management, provide a solid foundation for markets that require documentation, continuity of supply and clear response times.
3. Commercial opportunity
The portfolio structure makes it possible to work on high clinical need segments, with the opportunity to build a distinctive presence by therapeutic area and to evaluate agreements consistent with local market development.
4. Partnership model
Alfakjn supports its partners with technical and commercial materials, product interpretation support and a readiness to adapt positioning to different distribution contexts, whilst maintaining scientific and regulatory consistency.
Local presence, international vision
Alfakjn distributes through local partners in 23 countries and continues to evaluate entry into new markets. Our presence is focused on areas where Italian quality, regulatory robustness and the ability to offer differentiating devices can generate value for the distribution network.
Global products, local storytelling
A medical product does not enter every market in the same way. Clinical habits, commercial language, the level of maturity of the segment and the role of the distributor in the relationship with doctors and pharmacists all change.
For this reason, Alfakjn also works with its partners on how the product is presented locally: shared technical materials, market-adapted positioning, and the opportunity to enhance the brand or trade name most consistent with the target context.
In one of the Central European markets, a distribution partner has introduced an Alfakjn line under its own local commercial name, building a recognisable presence in the pharmacy channel and among healthcare professionals. The adaptation work has included translated technical materials, positioning support and alignment with local regulatory requirements—whilst maintaining full consistency with the quality and specifications of the original device.
